| 000 | 00845 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517175006.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2056-5933 | ||
| 024 | 7 |
_a10.1136/rmdopen-2017-000473 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDruce, Katie L | |
| 245 | 0 | 0 |
_aMortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic. _h[electronic resource] |
| 260 |
_bRMD open _c2017 |
||
| 300 |
_ae000473 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aIqbal, Kundan | |
| 700 | 1 | _aWatson, Kath D | |
| 700 | 1 | _aSymmons, Deborah P M | |
| 700 | 1 | _aHyrich, Kimme L | |
| 700 | 1 | _aKelly, Clive | |
| 773 | 0 |
_tRMD open _gvol. 3 _gno. 1 _gp. e000473 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/rmdopen-2017-000473 _zAvailable from publisher's website |
| 999 |
_c27609457 _d27609457 |
||